Theodore E. Schall, PhD, MSW, MBE, Kaitlyn Jaffe, PhD, and Jacob D. Moses, PhD
Clinicians should know how randomized controlled trials can and cannot contribute to advancing health equity for transgender and gender diverse people.
AMA J Ethics. 2024;26(9):E684-689. doi:
10.1001/amajethics.2024.684.
Erin Sharoni joins Ethics Talk to discuss her article: “Which Concepts Are Key to Transitioning From Nonhuman Animal Models to Engineered Microphysiological Systems in Biomedical Research?”
The possibility of nonhuman animals becoming legal persons and having better protections under the federal Animal Welfare Act is front and center here.
AMA J Ethics. 2024;26(9):E696-700. doi:
10.1001/amajethics.2024.696.
Dr David DeGrazia joins Ethics Talk to discuss why the “3 R’s” of nonhuman animal research might not be sufficient to promote good science, ethics, and nonhuman animal welfare.
Whether and to what extent constitutional equal protection should apply to some nonhuman animals can be considered in light of corporations having gained such protection.
AMA J Ethics. 2024;26(9):E690-695. doi:
10.1001/amajethics.2024.690.
Prashasti Bhatnagar joins Ethics Talk to discuss her article, coauthored with Dr Deborah F. Perry and Margaret E. Greer: “How Should We Measure Effectiveness of Medical-Legal Partnerships?”